lifestyle.pspl.com

Author: Aclarion, Inc.

Aclarion Announces $2.5 Million Stock Repurchase Plan

May 5, 2026
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

May 4, 2026
Aclarion Receives Pinnacle Award for AI Innovation

May 4, 2026
Aclarion Announces Agreement with Weill Cornell Medicine

May 3, 2026
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

May 3, 2026
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

May 1, 2026
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

May 1, 2026
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet

April 30, 2026
Aclarion CEO Brent Ness to Attend LSI USA 2026

April 29, 2026
Aclarion Publishes 2026 Shareholder Letter from the Chairman

February 12, 2026